If maintaining erectile function is a priority for someone on feminizing HRT, medical interventions are available:
This overview addresses the physiological aspects of erections for transgender individuals, specifically focusing on how gender-affirming hormone therapy (GAHT) and various surgical procedures influence erectile function. Hormonal Effects on Native Genitalia transsexual erections
For transgender men (AFAB) who undergo phalloplasty (the surgical creation of a phallus), the new genitalia do not contain erectile tissue (corpora cavernosa) and cannot become erect on their own. To achieve rigidity for penetrative intercourse, an is typically implanted after the initial phallus has healed: If maintaining erectile function is a priority for
For transgender women (AMAB) undergoing feminizing hormone therapy, the introduction of estrogen and the suppression of testosterone typically result in significant changes to erectile function: Medical Support and Management : A portion of
: Following surgery, sexual satisfaction is derived from nerve sensitivity and pelvic engorgement rather than the maintenance of a rigid external erection. Medical Support and Management
: A portion of the glans penis is often used to create a neo-clitoris. This tissue can still engorge with blood during arousal, providing a sensation similar to a natural clitoral erection.